Answers are grounded in this paper and cite their sources.
Real-world study shows IPSS-M improves risk prognostication and transplant selection in myelodysplastic syndromes, indicating the utility of defining a core gene set for clinical use.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sauta et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: